Shares of DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) have been assigned a consensus recommendation of “Hold” from the thirteen ratings firms that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $92.45.
DOCU has been the subject of several research reports. Morgan Stanley raised their target price on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research note on Friday, December 6th. Piper Sandler raised their price objective on shares of DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $90.00 target price (up from $57.00) on shares of DocuSign in a report on Friday, December 6th. UBS Group raised their target price on shares of DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a report on Friday, December 6th. Finally, Wells Fargo & Company upped their price target on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a report on Friday, December 6th.
View Our Latest Research Report on DocuSign
DocuSign Stock Performance
Insider Activity
In related news, CEO Allan C. Thygesen sold 7,763 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $80.54, for a total value of $625,232.02. Following the completion of the sale, the chief executive officer now directly owns 100,062 shares in the company, valued at approximately $8,058,993.48. This represents a 7.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Peter Solvik sold 10,000 shares of the firm’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $91.26, for a total value of $912,600.00. Following the transaction, the director now owns 150,253 shares in the company, valued at approximately $13,712,088.78. This trade represents a 6.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 685,773 shares of company stock worth $66,032,726 in the last ninety days. Corporate insiders own 1.66% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in DOCU. Synergy Financial Group LTD boosted its position in DocuSign by 3.4% during the fourth quarter. Synergy Financial Group LTD now owns 4,241 shares of the company’s stock worth $381,000 after purchasing an additional 140 shares during the period. M&T Bank Corp lifted its stake in shares of DocuSign by 1.3% in the fourth quarter. M&T Bank Corp now owns 10,840 shares of the company’s stock worth $975,000 after buying an additional 143 shares during the last quarter. Avior Wealth Management LLC boosted its holdings in shares of DocuSign by 36.5% during the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock worth $49,000 after buying an additional 145 shares during the period. Linden Thomas Advisory Services LLC grew its stake in DocuSign by 1.1% in the 4th quarter. Linden Thomas Advisory Services LLC now owns 13,540 shares of the company’s stock valued at $1,218,000 after buying an additional 149 shares during the last quarter. Finally, J.W. Cole Advisors Inc. raised its holdings in DocuSign by 2.0% in the 3rd quarter. J.W. Cole Advisors Inc. now owns 7,946 shares of the company’s stock worth $493,000 after acquiring an additional 155 shares during the period. 77.64% of the stock is owned by institutional investors.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
- Five stocks we like better than DocuSign
- How to Calculate Stock Profit
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.